home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  September 25, 2016
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 648 active entries

Gobal Napi Pharmaceuticals

st.18
6th october city
Egypt
Toll free: Dr.Nasr Meleka

Phone: +2028333354
Fax: +2028333351

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

Global Napi Pharmaceuticals is one of group of companies specialized in the field of manufacturing, promotion, import, export, and distribution of pharmaceuticals & cosmetics in Egypt. GNP is an Egyptian private sector investment pharmaceutical industry project founded under the investment law 230 of 1990, initiated in 1994, and started production in 1998. *Art of technology manufacturing plant is located at 6 October City industrial zone, Giza, Egypt. GNP assets 35 million Egyptian pound. GNP 2005 sales 160 million Egyptian pounds. GNP is a licensed pharmaceutical project, founded under the laws of investment. The plant is designed, built and equipped with the most updated GMP specifications. GNP is provided by the most reputable, high technology pharmaceutical grade machinery and control laboratory. Production and Quality control are all designed according to the rules of the International pharmaceutical Industry. G.N.P production, research and quality assurance, follow the most modern and advanced current good manufacturing practice (CGMPS) set forth by the world health organization (WHO). G.N.P products were carefully selected to meet the local and export market needs, and to substitute the imported products. G.N.P is paying much attention to research and development. G.N.P acquired the Total Quality Management Certificate (ISO 9001) from the American system register (ASR ). And also acquired the Certificate of Environmental Management System (ISO 14001) from the American system register (ASR ). GNP is audited by several multinational companies, the licensors, on regular basis who are manufacturing a wide range of their products in our facility. Licensors are : MSD - USA Sanofi Aventis - France Boehringer Ingelheim – Germany Wyeth - USA Elerte - France Bayer Health Care – Germany Pierre Fabre – France Grimberg - France Biox Novapharm – Germany Help - Greece Stada - Germany GNP possesses a well carefully selected product portfolio representing major therapeutic classes:  Cardio – Vascular.  Anti Inflammatory.  Respiratory Tract.  Anti Infective.  Gastro Intestinal.  Central Nervous System.  Dermatological Preparations.  Food supplements and Natural Products. GNP products are classified into two lines of products: - National products (mostly are generics) - Licensed products (manufactured under license of the previously mentioned licensors. Please don’t hesitate to any requirements needed. Hoping a fruitful cooperation with our companies. Thanks & Best Regards, International Marketing Manager Dr.Nasr Meleka

Selected Categories:

Product Company   Service Company
Pharmaceutical
- General
Supplier
- Distributor
- Medical
Contract
- Production

Last update of this entry: October 02, 2006

Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.